Israel has made significant theoretical and practical contributions to the biotechnology revolution and has developed an advanced infrastructure of medical and paramedical research as well as bioengineering capabilities. Biotechnology, biomedical, and clinical research account for over half of all scientific publications. The country’s industrial sector has increased its activities in the medical field to capitalize on its extensive knowledge base.
Local scientists have developed methods for producing a human growth hormone and interferon, a group of proteins effective against viral infections. Copaxone, a medicine effective in the treatment of multiple sclerosis, was developed in Israel - from basic research to industrial production. Genetic engineering, has resulted in a wide range of diagnostic kits based on monoclonal antibodies, along with other microbiological products.
Sophisticated medical equipment for both diagnostic and treatment purposes has been developed and marketed worldwide, such as computer tomography (CT) scanners, magnetic resonance imaging (MRI) systems, ultrasound scanners, nuclear medical cameras, and surgical lasers. Other innovations include a controlled-release liquid polymer to prevent accumulation of tooth plaque, a device to reduce both benign and malignant swellings of the prostate gland, the use of botulin to correct eye squint, and a miniature camera encased in a swallowable capsule used to diagnose gastro-intestinal disease.